Multifunctionality of Prostatic Acid Phosphatase in Prostate Cancer Pathogenesis.

androgen sensitivity human prostatic acid phosphatase prostate cancer signal sequence

Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
04 Oct 2021
Historique:
accepted: 04 10 2021
received: 14 07 2021
revised: 18 09 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 5 10 2021
Statut: aheadofprint

Résumé

The role of human prostatic acid phosphatase (PAcP, P15309|PPAP_HUMAN) in prostate cancer was investigated using a new proteomic tool termed signal sequence swapping (replacement of domains from the native cleaved amino terminal signal sequence of secretory/membrane proteins with corresponding regions of functionally distinct signal sequence subtypes). This manipulation preferentially redirects proteins to different pathways of biogenesis at the endoplasmic reticulum, magnifying normally difficult to detect subsets of the protein of interest. For PAcP this technique reveals three forms identical in amino acid sequence but profoundly different in physiological functions, subcellular location, and biochemical properties. These three forms of PAcP can also occur with the wild-type PAcP signal sequence. Clinical specimens from patients with prostate cancer demonstrate that one form, termed PLPAcP, correlates with early prostate cancer. These findings confirm the analytical power of this method, implicate PLPAcP in prostate cancer pathogenesis, and suggest novel anticancer therapeutic strategies.

Identifiants

pubmed: 34605872
pii: 229875
doi: 10.1042/BCJ20200944
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright 2021 The Author(s).

Auteurs

Evgenia Alpert (E)

Bioconformatics laboratory of the California Pacific Medical Center (CPMC) Research Institute, Ramat-Gan, California, United States.

Armin Akhavan (A)

Bioconformatics Laboratory of the California Pacific Medical Center (CPMC) Research Institute, San Francisco, California, United States.

Arie Gruzman (A)

Bioconformatics Laboratory of the California Pacific Medical Center (CPMC) Research Institute, San Francisco, California, United States.

William J Hansen (WJ)

Prosetta Corporation, San Francisco, California, United States.

Joshua Lehrer-Graiwer (J)

Bioconformatics Laboratory of the California Pacific Medical Center (CPMC) Research Institute, San Francisco, California, United States.

Steven C Hall (SC)

UCSF, San Francisco, California, United States.

Eric Johansen (E)

UCSF, San Francisco, California, United States.

Sean McAllister (S)

Cancer Laboratory of the California Pacific Medical Center (CPMC) Research Institute, San Francisco, California, United States.

Mittul Gulati (M)

UCSF, San Francisco, California, United States.

Ming-Fong Lin (MF)

University of Nebraska Medical Center, Omaha, Nebraska, United States.

Vishwanath R Lingappa (VR)

Bioconformatics Laboratory of the California Pacific Medical Center (CPMC) Research Institute, San Francisco, California, United States.

Classifications MeSH